Why Progenics
-
Our laboratory is dedicated to the processing and cryopreservation of human umbilical cord blood and cord tissue stem cells.
-
We use the unique, modified double stem cell extraction processing technique developed by Progenics’ Research & Development Team.
-
Our protocols are designed with safeguards against possible human error, equipment malfunction and power failures.
-
We are committed to processing cord blood and cord tissue units within the first 24 hours from collection.
-
A certificate of cryopreservation that includes improtant quality indicators will be issued to the parents.
Consistent High Quality
Get the Most out of Your Cord Blood
The quantity and viability of stem cells extracted from cord blood units are critical parameters for a successful transplantation. Progenics consistently yields a high average of 98% of Total Nucleated Cells (TNCs) from all cord blood units processed between the years of 2014-2018 (Graph on the left).
Click here from more details from our annual quality report.
-
急性白血病急性混合型白血病 急性淋巴性白血病 急性骨髓性白血病 急性未分化性白血病
-
CHRONIC LEUKEMIAS慢性淋巴球白血病 慢性骨髓性白血病 青少年慢性骨髓性白血病 青少年骨髓單核細胞性白血病
-
骨髓發育不良症候群澱粉樣變性病 慢性骨髓單核細胞性白血病 頑固性貧血過量芽細胞頑固性貧血 過量芽細胞頑固性貧血合併急性轉化 環形鐵粒幼細胞性難治性貧血
-
幹細胞病變再生不良貧血 先天性血球胞缺乏症 先天性角化不良 範康尼貧血 陣發性夜間血紅素尿症